
It wasn’t so long ago that pharmaceutical companies could change the prices of its products with little scrutiny. A series …

Ironwood Pharmaceuticals has announced that the FDA has approved its drug Duzallo for the treatment of hyperuricemia associated with gout …

It has been revealed that private hospitals being run across England and Wales will receive £52 million in tax breaks …

Owen Marks, Country Head for the Rare Disease Unit at Pfizer UK, discusses his career so far and what drives …

Researchers from Vanderbilt University have discovered a previously unknown ability of a compound in mother’s milk to protect new-borns from …

A pair of US Congressmen have fired allegations at Israeli drugmaker Teva accusing the firm of hiking the price of …

Thus far, Samsung Bioepis has made its name by being a thorn in the side of the producers of original …

A research group at the Sahlgrenska Academy at the University of Gothenburg in Sweden have released findings rebutting the claim …

Novartis, alongside Medicines for Malaria Venture (MMV), have revealed that trials into a new antimalarial compound have begun in a …

A lot has happened in the world this week, but the pharma industry still found itself on the frontlines of …

The prices of generic drugs have been driven lower as companies compete to undercut one another. This has led to …

Pfizer has received a bittersweet bout of news as it emerges that its drug Besponsa (inotuzumab ozogamicin) has received approval …

It was a case of three-in-one bits of good news for AstraZeneca and MSD, after the FDA boosted the newly …

Newcastle upon Tyne Hospital’s Chief Executive, Leonard Fenwick, has been sacked from his position after a disciplinary panel adjudged he …

British Heart Foundation’s Jennifer Mitchell, Research Communications Officer, explains the work they are doing to find the next breakthrough treatment …